REVIEW
|
doi:10.20944/preprints202405.0212.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Hepatocellular carcinoma (HCC); systemic therapies; bridging; liver transplantation (LT); Tyrosine Kinase Inhibitors (TKIs); Immune Checkpoint Inhibitors (ICIs)
Online: 6 May 2024 (04:52:05 CEST)